Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells

Biochemical Pharmacology

Volumn 86, Issue 9, 2013, Pages 1254-1262

  Han, Yang Yang ^a   Liu, Hong Yan ^a   Han, Dong Ju ^a   Zong, Xi Cui ^a   Zhang, Shuang Quan ^a   Chen, Yu Qing ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Antibacterial peptide; Breast cancer; Gangliosides; Glycoproteins; Selectivity; Sialic acid

Indexed keywords

AUREIN 1.2; BMAP 28; BUFORIN II2B; CD31 ANTIGEN; GANGLIOSIDE; GLYCOPROTEIN; N GLYCOPROTEIN; O GLYCOPROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; SIALIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CANCER CELL; CELL SURFACE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; FLOW CYTOMETRY; GROWTH INHIBITION; HEMOLYSIS; IN VIVO STUDY; LIVER CELL; MOUSE; NICK END LABELING; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION;

Α2; 4′,6-DIAMIDINO-2-PHENYLINDOLE; 6-SIALYLTRANSFERASE; ABPS; ANTIBACTERIAL PEPTIDE; ANTIBACTERIAL PEPTIDES; BENZYL-2-ACETAMIDO-2-DEOXY-A-D-GALACTOPYRANOSIDE; BNGALNAC; BREAST CANCER; DAPI; DMEM; DULBECCO'S MODIFIED EAGLE'S MEDIUM; FBS; FETAL BOVINE SERUM; FITC; FITC LABELED SAMBUCUS NIGRA AGGLUTININ; FITC-SNA; FLUORESCEIN ISOTHIOCYANATE; GANGLIOSIDES; GAPDH; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLYCOPROTEINS; H&E; HEMATOXYLIN AND EOSIN; HST6GAL1; HUMAN Β-GALACTOSIDE; L-PPMP; MEAN VASCULAR DENSITY; METHYL THIAZOLYL TETRAZOLIUM; MTT; MVD; PARP; PBS; PHENYL-2-HEXADECANOYAMINO-3-MORPHOLINO-1-PROPANOL HYDROCHLORIDE; PHOSPHATE-BUFFERED SALINE; POLY ADP-RIBOSE POLYMERASE; SELECTIVITY; SIALIC ACID; TACAS; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-MEDIATED DUTP-BIOTIN NICK END LABELING; TUMOR-ASSOCIATED CARBOHYDRATE ANTIGENS; TUNEL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CHO CELLS; CRICETULUS; FEMALE; GANGLIOSIDES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; N-ACETYLNEURAMINIC ACID; PEPTIDES; PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84886719383     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.08.008     Document Type: Article

References (38)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. S. Riedl, D. Zweytick, and K. Lohner Membrane-active host defense peptides - challenges and perspectives for the development of novel anticancer drugs Chem Phys Lipids 164 2011 766 781
3. N. Papo Shai Y.Host defense peptides as new weapons in cancer treatment Cell Mol Life Sci 62 2005 784 790
4. D.W. Hoskin, and A. Ramamoorthy Studies on anticancer activities of antimicrobial peptides Biochim Biophys Acta 1778 2008 357 375
5. Schweizer F.Cationic amphiphilic peptides with cancer-selective toxicity Eur J Pharmacol 625 2009 190 194
6. S.R. Dennison, F. Harris, and D.A. Phoenix The interactions of aurein 1.2 with cancer cell membranes Biophys Chem 127 2007 78 83
7. H.S. Lee, C.B. Park, J.M. Kim, S.A. Jang, I.Y. Park, and M.S. Kim Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide Cancer Lett 271 2008 47 55
8. A. Ahmad, N. Asthana, S. Azmi, R.M. Srivastava, B.K. Pandey, and V. Yadav Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences Biochim Biophys Acta 1788 2009 2411 2420
9. M. Zaiou Multifunctional antimicrobial peptides: therapeutic targets in several human diseases J Mol Med (Berl) 85 2007 317 329
10. J.H. Park, Y.J. Jeong, K.K. Park, H.J. Cho, I.K. Chung, and K.S. Min Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression Mol Cells 29 2010 209 215
11. M. Jo, M.H. Park, P.S. Kollipara, B.J. An, H.S. Song, and S.B. Han Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway Toxicol Appl Pharmacol 258 2012 72 81
12. V. Teixeira, M.J. Feio, and M. Bastos Role of lipids in the interaction of antimicrobial peptides with membranes Prog Lipid Res 51 2012 149 177
13. H. Schröder-Borm, R. Bakalova, and J. Andrä The NK-lysin derived peptide NK-2 preferentially kill cancer cells with increased surface levels of negatively charged phosphatidylserine FEBS Lett 579 2005 6128 6134
14. T. Iwasaki, J. Ishibashi, H. Tanaka, M. Sato, A. Asaoka, and D. Taylor Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface Peptides 30 2009 660 668
15. N. Papo, and Y. Shai New lytic peptides based on the d,l-ABP hipathic helix motif preferentially kill tumor cells compared to normal cells Biochemistry 42 2003 9346 9354
16. P.H. Wang Altered sialylation and its roles in gynecologic cancers J Cancer Mol 2 2006 107 116
17. C. Ohyama Glycosylation in bladder cancer Int J Clin Oncol 13 2008 308 313
18. A. Lityńska, M. Przybyło, D. Hoja-Łukowicz, E. Pocheć, M. Kremser, and D. Ciołczyk-Wierzbicka Protein glycosylation as marker of melanoma progression Curr Cancer Thera Rev 4 2008 144 148
19. A. Cazet, S. Julien, M. Bobowski, J. Burchell, and P. Delannoy Tumour-associated carbohydrate antigens in breast cancer Breast Cancer Res 12 2010 204 216
20. K. Lavrsen, C.B. Madsen, M.G. Rasch, A. Woetmann, N. Odum, and U. Mandel Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity Glycoconj J 30 2013 227 236
21. R.E. Beatson, J. Taylor-Papadimitriou, and J.M. Burchell MUC1 immunotherapy Immunotherapy 2 2010 305 327
22. D.K. Banerjee N-glycans in cell survival and death: cross-talk between glycosyltransferases Biochim Biophys Acta 1820 2012 1338 1346
23. M.L. De Leoz, L.J. Young, H.J. An, S.R. Kronewitter, J. Kim, and S. Miyamoto High-mannose glycans are elevated during breast cancer progression Mol Cell Proteomics 10 2011 1 9
24. P.H. Lopez, and R.L. Schnaar Gangliosides in cell recognition and membrane protein regulation Curr Opin Struct Biol 19 2009 549 557
25. Y.Q. Chen, C. Min, M. Sang, Y.Y. Han, X. Ma, and X.Q. Xue A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells Peptides 31 8 2010 1504 1510
26. P. Mukhopadhyay, S. Chakraborty, M.P. Ponnusamy, I. Lakshmanan, M. Jain, and S.K. Batra Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy Biochim Biophys Acta 1815 2011 224 240
27. G. Marquina, H. Waki, L.E. Fernandez, K. Kon, A. Carr, and O. Valiente Gangliosides expressed in human breast cancer Cancer Res 56 1996 5165 5171
28. A. Risso, M. Zanetti, and R. Gennaro Cytotoxicity and apoptosis mediated by two peptides of innate immunity Cell Immunol 189 1998 107 115
29. J. Weghuber, M.C. Aichinger, M. Brameshuber, S. Wieser, V. Ruprecht, and B. Plochberger Cationic amphipathic peptides accumulate sialylated proteins and lipids in the plasma membrane of eukaryotic host cells Biochim Biophys Acta 1808 2011 2581 2590
30. T. Miyagi, T. Wada, K. Yamaguchi, and K. Hata Sialidase and malignancy. A minireview Glycoconj J 20 2004 189 198
31. S. Gross, and J. Andrä Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids Biol Chem 393 2012 817 827
32. B. Fadnes, L. Uhlin-Hansen, I. Lindin, and O. Rekdal Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells BMC Cancer 11 2011 116
33. S. Nowsheen, K. Aziz, M.I. Panayiotidis, and A.G. Georgakilas Molecular markers for cancer prognosis and treatment: have we struck gold Cancer Lett 327 2012 142 152
34. F. Marmé, and A. Schneeweiss Personalized therapy in breast cancer Onkologie 35 2012 28 33
35. N. Harbeck, M. Salem, U. Nitz, O. Gluz, and C. Liedtke Personalized treatment of early-stage breast cancer: present concepts and future directions Cancer Treat Rev 36 2010 584 594
36. D. Raina, R. Ahmad, M.D. Joshi, L. Yin, Z. Wu, and T. Kawano Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells Cancer Res 69 2009 5133 5141
37. J. Heimburg-Molinaro, M. Lum, G. Vijay, M. Jain, A. Almogren, and K. Rittenhouse-Olson Cancer vaccines and carbohydrate epitopes Vaccine 29 2011 8802 8826
38. M.D. Walsh, S.M. Luckie, M.C. Cummings, T.M. Antalis, and M.A. McGuckin Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro Breast Cancer Res Treat 58 1999 253 264